483
OneBlood, Inc.FDA 483 - OneBlood, Inc. - January 09, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of OneBlood, Inc. in Thomasville, GA, on January 9, 2026, revealed a significant concern regarding phlebotomy site preparation. The inspection found that phlebotomists failed to maintain the sterility of the venipuncture site by allowing non-sterile items to touch the disinfected area during whole blood collections. This practice raises concerns about the assurance of a sterile container of Whole Blood.
Open in Dashboard
ID · 2476101a-606d-423b-a45d-84ff946aed81